Study Links Breast Surgery to Longer Survival in HER2-Positive Metastatic Breast Cancer

A new study suggests that breast surgery is associated with significantly improved overall survival in carefully selected patients with HER2-positive de novo metastatic breast cancer. The research, published in *Breast Cancer Research and Treatment*, found a roughly two-thirds reduction in the risk of death for patients who underwent surgery compared to those treated without it, after adjusting for other factors.